Brief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
26/03/2025 11:50
March 26 (Reuters) - Rafael Holdings Inc RFL.N: RAFAEL HOLDINGS COMPLETES MERGER WITH CYCLO THERAPEUTICS FOLLOWING SHAREHOLDER APPROVALS Source text: ID:nGNX3NxK9m Further company coverage: RFL.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rafael Holdings
See all newsBrief: Rafael Holdings Announces Topline Results From The Pivotal Phase 3 Transportnpc™ Study Of Trappsol® Cyclo™ In Niemann-Pick Disease Type C (Npc)
Israel expects new air defence orders from Europe due to Russia concerns
Biotech firm Rafael's Q3 net loss narrows; set to submit NDA for Trappsol Cyclo in H2
Rafael Holdings Q2 net loss widens on consolidation of Cyclo Therapeutic's costs
Brief: Rafael Holdings Q2 Net Income USD -6.327 Million